Market research report projects that the market will grow to more than $2.5 billion by 2008, a compound annual growth rate of more than 14%
The proteomics market grew from $1.1 billion in 2001 to almost $1.4 billion in 2002 and, according to a new report by Select Biosciences, the growth rate is continuing in 2003.
Prepared in San Francisco, California by Steven Bodovitz, Proteomics 2003 presents a detailed market model and thorough analysis of the technologies and business strategies of 75 leading proteomics companies.
Proteomics 2003 projects that the market will grow to more than $2.5 billion by 2008, a compound annual growth rate of more than 14%.
Proteomics 2003 is based on extensive primary and secondary research, including interviews with company representatives.
It discusses the background of the three main market applications: drug target /biomarker discovery and validation, drug development, and clincal trials and diagnostics.
It provides in-depth information on the market, size segmented by technology and application.
In addition to a detailed market model, Proteomics 2003 evaluates the strengths and weaknesses of each of the proteomics vendors, and assesses both opportunities and threats facing their products and services.
Proteomics 2003 identifies the companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward.
